BioZ gains local coverage
This article was originally published in The Gray Sheet
Executive Summary
CardioDynamics snags expanded coverage of its BioZ impedance cardiography (ICG) technology with policy reversals from two local Medicare contractors, the firm announces Aug. 7. The contractors for patients in Mississippi, Alabama, Georgia and South Carolina will now cover the noninvasive test to guide treatment of high blood pressure. CMS denied national coverage of the hypertension indication in a November 2006 decision, but left discretion up to local carriers (1"The Gray Sheet" Nov. 27, 2006, In Brief). According to CEO Michael Perry, the firm has "begun to experience a recovery in its ICG business" during the past two quarters...